Drugs / Tacrollimus
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06362005 | May 2024 → Jul 2025 | lichen planus, oral | Al-Azhar University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tacrollimus | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06362005 ↗ |
| Route | Topical | “receive topical tacrolimus 0.1% four times per day for six weeks” NCT06362005 ↗ |